top of page
Bevespi Aerosphere Inhalation Aerosol is a combination medication containing an anticholinergic, glycopyrrolate,a long-acting beta2-adrenergic agonist (LABA), and formoterol fumarate. Bevespi Aerosphere is used as maintenance treatment forchronic obstructive pulmonary disease (COPD).

Bevespi Aerosphere (Glycopyrrolate/Formoterol fumarte)

  • Bevespi Aerosphere is available as a pressurized metered dose inhaler for inhalation by mouth. Follow the instructions that come with your prescription. The dose for maintenance treatment of COPD is 2 puffs by mouth twice daily. Each puff delivers 9 mcg glycopyrrolate and 4.8 mcg of formoterol fumarate.
bottom of page